NASDAQ:BSPM

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

XIANYANG, China, April 23, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina, announced today that on received a notification letter from Nasdaq Listing Qualifications (...

2018-04-24 04:00 456

Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform

XIANYANG, China, Feb. 21, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its plans to launch a new e-c...

2018-02-21 22:00 533

Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification

XIANYANG, China, Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina for a variety of diseases and conditions, today announced that its variable inter...

2018-02-07 22:00 524

Biostar Regains Compliance with NASDAQ Continued Listing Requirement

XIANYANG, China, Dec. 4, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina, announced that onNovember 30, 2017, it received a letter from the NASDAQ Listing ...

2017-12-05 05:30 577

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017

XIANYANG, China, Nov. 20, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina for a variety of diseases and conditions, today announced its financial results ...

2017-11-21 05:01 652

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017

XIANYANG, China, Nov. 15, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina for a variety of diseases and conditions, today announced its financial results f...

2017-11-16 05:30 726

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

XIANYANG, China, Aug. 28, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina, announced today that on August 22, 2017 it received a notification letter from Nasdaq Listin...

2017-08-29 04:00 1912

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017

XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina for a variety of diseases and conditions, today announced its financial results fo...

2017-05-20 04:30 3222